Discover 1,538 paid clinical trials in Paterson, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,538
Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
for
Major Depressive Disorder
Location: 32 recruiting locations
Sponsor: Neumora Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06058013
Phase3, Recruiting
Active & Responsive
CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: 143 recruiting locations
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase3, Recruiting
Active & Responsive
Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care
for
Arthritis, Rheumatoid
Location: 35 recruiting locations
Sponsor: Crescendo Bioscience
Sex: All
Age: 18 - 70+
Code: NCT02832297
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Location: 90 recruiting locations
Sponsor: Cleerly, Inc.
Sex: All
Age: 55+
Code: NCT06112418
Recruiting
Active & Responsive
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
for
Non Small Cell Lung Cancer,
Location: 117 recruiting locations
Sponsor: PrECOG, LLC.
Sex: All
Age: 18+
Code: NCT06538038
Recruiting
Active & Responsive
GnRH for Luteal Support in IVF/ICSI/FET Cycles
for
Infertility
Location: 1 recruiting location
Sponsor: University Reproductive Associates
Sex: Female
Age: 18 - 40
Code: NCT02357654
Recruiting
Active & Responsive
Pembrolizumab and Lenvatinib in Advanced Cervical Cancer
for
Cervical Cancer, Metastatic Cervical Cancer
Location: 3 recruiting locations
Sponsor: Georgetown University
Sex: Female
Age: 18+
Code: NCT04865887
Phase2, Recruiting
Active & Responsive
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma